Dk. Kim et al., SYNTHESIS AND EVALUATION OF -HYDROXYMETHYL-4-ALKOXYCARBONYLOXYBUT-1-YL)PURINES AS POTENTIAL PRODRUGS OF PENCICLOVIR, Journal of medicinal chemistry, 41(18), 1998, pp. 3435-3441
A series of -hydroxymethyl-4-alkoxycarbonyloxybut-1-yl)purines (4-10)
and 2-amino-9-(2-(2-oxo-1,3-dioxan-5-yl)ethyl)purine (1) were synthesi
zed as potential prodrugs of penciclovir and evaluated for their oral
penciclovir bioavailability in mice and rats. Treatment of 2-(2-benzyl
oxyethyl)propane-1,3-diol (11) with 1,1'-carbonyldiimidazole in THF fo
llowed by hydrogenolytic removal of the benzyl group of the resulting
cyclic carbonate 12 gave 5-(2-hydroxyethyl)-1,3-dioxan-2-one 13). Mesy
lation of the alcohol 13 and then a coupling reaction of the resulting
mesylate 14 with 2-amino-6-chloropurine using anhydrous Cs2CO3 in DMF
afforded -6-chloro-9-(2-(2-oxo-1,3-dioxan-5-yl)ethyl)purine (16) afte
r purification by flash column chromatography on silica gel using EtOA
c/MeCN/Et3N as eluent. Hydrogenation of the 6-chloro cyclic carbonate
16 followed by a ring-opening reaction of the 6-deoxy cyclic carbonate
1 in a mixture of an appropriate alcohol and CHCl3 using activated Si
O2 as a Lewis acid afforded the corresponding alkyl monocarbonate deri
vatives 3-10 in fair to good yields. Of the prodrugs tested in mice, t
he isopropyl monocarbonate 6 achieved the highest mean urinary recover
y of penciclovir (53%), followed in order by the propyl monocarbonate
6 (51%), the isopentyl monocarbonate 10 (51%), the ethyl monocarbonate
4 (50%), and famciclovir (48%). In rats, the methyl monocarbonate 3,
4, 6, the n-butyl monocarbonate 7, and 10 (39-41%) showed levels of me
an urinary recovery of penciclovir similar to that from famciclovir (4
0%). The alkyl monocarbonates 4-10 were found to be quite stable in th
e aqueous buffer solutions, and among them, 6 was the most stable with
the half-lives (t(1/2)) of 88, >200, 61, and 26 days at pH 1.2, 6.0,
7.4, and 8.0, respectively. In addition, 6 was highly soluble in H2O (
138.8 mg/ mt, 20 degrees C).